Endometriosis ~ Abdominal Pain ~ Endo ~ Scar Tissue ~ Adhesions ~ Infertility ~ Hysterectomy
Showing posts with label lesions. Show all posts
Showing posts with label lesions. Show all posts

Friday, May 02, 2014

First Harry Reich Award presented at EFA’s Blossom Ball

First Harry Reich Award presented at EFA’s Blossom Ball 
8 MARCH 2014
Professors Linda Giudice and Liselotte Mettler were honoured at EFA’s 6th Annual Blossom Ball with the inaugural Harry Reich Award.

Yesterday evening, the Endometriosis Foundation of America (EFA) awarded the inaugural Harry Reich Award to recognise two extraordinary healthcare professionals, Professors Linda Giudice and Liselotte Mettler, for the difference these two women have made in the lives of other women through their practice, research, and advocacy.

Tamer Seckin presenting Linda Giudice with her Award at the Blossom Ball
In announcing these two awards, co-founder of EFA, Dr Tamer Seckin, emphasised how the achievements of both Linda Giudice and Liselotte Mettler are an inspiration and encouragement for women (with and without endometriosis) to take charge of their health!
Professor Giudice is a biochemist, gynaecologist, and reproductive endocrinologist with a specific clinical interest in endometriosisinfertilityassisted reproduction, and implantation and ovulatory disorders.
Her research focuses on environmental impacts on reproductive health, steroid hormone signalling in human endometrium, endometrial-placental interactions, endometrium as a mucosal tissue, and translational applications of human embryonic and endometrial stem cells.  She is distinguished professor and chair of the Department of Reproductive Sciences at the University of California San Francisco, immediate past-president of the ASRM, president-elect of the World Endometriosis Society, vice-president of the World Endometriosis Research Foundation, and a member of the Institute of Medicine of the National Academy of Sciences.
Tamer Seckin presenting Liselotte Mettler with her Award at the Blossom Ball
Professor Emeritus Mettler has specialised in reproductive medicine, gynaecological endoscopy, endometriosis, and gynaecological endocrinology since 1981 when she became deputy director of the Department of Obstetrics and Gynaecology at the University of Kiel.  Following her retirement she remains an honorary patron of the Kiel School of Gynaecological Endoscopy and Reproductive Medicine, where she still teaches up to a dozen international training courses each year.
She is also visiting professor to the German Medical Center and the Dubai Healthcare City.  Professor Mettler is a former board member and current ambassador of the World Endometriosis Society, a board member of the German Foundation for Endometriosis Research (SEF), and the General Secretary of the International Academy of Human Reproduction.

The Harry Reich Award

The Harry Reich Award is awarded by EFA to recognise extraordinary healthcare professionals, who are making a difference in women’s lives (and their families) by their practice, research, and advocacy.

Harry Reich with honouree Linda Giudice at the Blossom Ball
The award is named for Dr Harry Reich, a pioneer in the field of laparoscopic surgery, who performed many “firsts”, including: the first laparoscopic hysterectomy, the first pelvic lymphadenectomy for cancer, and the first excision of cul-de-sac endometriosis that included rectal resection.
Dr Reich, who has operated in more than 60 countries, is an honorary professor in Russia and Romania, as well as a Fellow (ad eundem) of the Royal College of Obstetricians and Gynaecologists in the UK for his pioneering work in the field of endoscopy.  Though retired, Dr Reich remains actively involved in many medical organisations and serves as a reviewer for multiple scientific journals.
Please visit Endometriosis.org for more news about endo.

Wednesday, April 16, 2014

Researchers to present at the World Congress on Endometriosis in Brazil

 Updated 4 hours agoSPECIAL TO HNN PROVIDED BY MARSHALL UNIVERSITY
HUNTINGTON, W.Va. - Two investigators from the Joan C. Edwards School of Medicine at Marshall University will be traveling later this month to Sao Paolo to present their research at the World Congress on Endometriosis.
The congress is held every three years and brings together scientists, clinicians, nurses and other healthcare professionals involved in research or treatment of endometriosis a chronic, inflammatory condition that affects young women and adversely impacts their fertility and quality of life.

Dr. Nalini Santanam, a professor in the Department of Pharmacology, Physiology and Toxicology, and biomedical sciences doctoral student Kristeena Ray said they are looking forward to participating in the conference, which is being held April 30-May 3.
"Though 10 to 15 percent of young women suffer from endometriosis and almost two-thirds of these women suffer from chronic pain, the exact nature of this disease is not very well understood. My laboratory has a long-standing interest in understanding why some women get endometriosis and have pain," said Santanam. "We are very honored that our abstracts were chosen for presentation at this meeting. The most exciting part was to find out that Kristeena was selected to give an oral presentation and was one of only six investigators selected to receive the Rodolphe Maheux Travel Grant."

Friday, April 11, 2014

MIT bioengineer works to unravel endometriosis

By Carolyn Y. Johnson / Globe Staff

Linda Griffith, a biological engineer at MIT who used a new technique to begin to unravel the molecular cause of endometriosis.
For four years, MIT bioengineer Linda Griffith has been slowly unraveling the biology of endometriosis, a complicated and poorly understood disease that she has silently struggled with her entire life. The condition—in which tissue normally found in the uterus grows elsewhere in the body—is remarkably common. It causes severe pain and infertility and affects up to 10 percent of women, yet relatively little is known about what causes it, how to prevent it, or even how to effectively treat it.

Saturday, March 15, 2014

Saturday, March 01, 2014

Endometriosis Awareness 2014

Endometriosis Awareness 2014

Endometriosis Awareness takes place across the globe during the month of March with a mission to raise awareness of “the invisible disease”, which affects an estimated 176 million women.

Read More about awareness across the world dor the month of March!

Wednesday, January 29, 2014

What it costs to have endometriosis

 2007 Apr;13(3):262-72.

Actuarial analysis of private payer administrative claims data for women with endometriosis.

Abstract

BACKGROUND:

Endometriosis is a painful, chronic disease affecting 5.5 million women and girls in the United States and Canada and millions more worldwide. The usual age range of women diagnosed with endometriosis is 20 to 45 years. Endometriosis has an estimated prevalence of 10% among women of reproductive age, although estimates of prevalence vary greatly. Endometriosis is the most common gynecological cause of chronic pelvic pain, but published information on its associated medical care costs is scarce.

OBJECTIVE:

The aim of this study was to determine (1) the prevalence of endometriosis in the United States, (2) the amount of health care services used by women coded with endometriosis in a commercial medical claims database during 1999 to 2003, and (3) the endometriosis-related costs for 2003, the most recent data available at the time the study was performed.

METHODS:

This study was a retrospective review of administrative data for commercial payers, which included enrollment, eligibility, and claims payment data contained in the Medstat Marketscan database for approximately 4 million commercial insurance members. All claims and membership data were extracted for each woman aged 18 to 55 years who had at least 1 medical or hospital claim with a diagnosis code for endometriosis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 617.00-617.99) for 1999 through 2003. Claims data from 1999 through 2003 were used to determine prevalence and health care resource utilization (i.e., annual admission rate, annual surgical rate, distribution of endometriosis-related surgeries, and prevalence of comorbid conditions). The cost analysis was based on claims from 2003 only. Cost was defined as the payer-allowed charge, which equals the net payer cost plus member cost share.

RESULTS:

The prevalence of women with medical claims (inpatient and/or outpatient) containing ICD-9-CM codes for endometriosis was 1.1% for the age band of 30 to 39 years and 0.7% over the entire age span of 18 to 55 years. The medical costs per patient per month (PPPM) for women with endometriosis were 63% greater ($706 PPPM) than those of the average woman per member per month ($433) in 2003; inpatient hospital costs accounted for 32% of total direct medical costs. Between 1999 and 2003, these women with endometriosis who were identified by either inpatient and/or outpatient claims had high rates of hospital admission (53% for any reason; 38% for an endometriosis-related reason) and a high annual surgical procedure rate (64%). Additionally, women with endometriosis frequently suffered from comorbid conditions, and these conditions were associated with greater PPPM costs of 15% to 50% for women with an endometriosis diagnosis code, depending on the condition. Interstitial cystitis was associated with 50% greater cost ($1,061 PPPM); depression, 41% ($997 PPPM); migraine, 40% ($988 PPPM); irritable bowel syndrome, 34% ($943 PPPM); chronic fatigue syndrome, 29% ($913 PPPM); abdominal pain, 20% ($846 PPPM); and infertility, 15% ($813 PPPM).

CONCLUSIONS:

Women with endometriosis have a high hospital admission rate and surgical procedure rate and a high incidence of comorbid conditions. Consequently, these women incur total medical costs that are, on average, 63% higher than medical costs for the average woman in a commercially insured group.
PMID:
 
17407392
 
[PubMed - indexed for MEDLINE] 
Fre

Thursday, December 05, 2013

Pesticides Linked to Endometriosis Risk



Why some women and not others get endometriosis — the growth of uterine tissue outside the uterus that can cause pain and infertility — is not known, but researchers have come up with one possible contributing factor: pesticide poisoning.
Scientists studied 248 women with surgically confirmed endometriosis and 538 healthy controls. They measured blood levels of two pesticides, mirex and beta HCH, which persist in some fish and dairy products even though their use in the United States has been banned for decades. The studyappears online in Environmental Health Perspectives.

Monday, October 28, 2013

The Role of DJ-1 in the Pathogenesis of Endometriosis

Some light reading...

PLoS One. 2011; 6(3): e18074.
Published online 2011 March 21. doi:  10.1371/journal.pone.0018074
PMCID: PMC3061880

The Role of DJ-1 in the Pathogenesis of Endometriosis

Jean-Marc Vanacker, Editor

Abstract

Background

Endometriosis is an estrogen-dependent disease causing pelvic pain and infertility in 10% of reproductive-aged women. Despite a long history of the disease the pathogenesis of endometriosis is poorly understood. It is known that the expression of several proteins is either up or down regulated during endometriosis, but their precise role remains to be determined. DJ-1 is one such protein that is upregulated in eutopic endometrium of women having endometriosis suggesting that DJ-1 may be involved in the pathogenesis of endometriosis

Sunday, March 04, 2012

International Endometriosis Awareness Month

Media release from Endometriosis New Zealand
Endometriosis New Zealand
Friday 02 March 2012, 2:06PM

Media release from Endometriosis New Zealand

International Endometriosis Awareness month will be launched in New Zealand at the International Women's Day Breakfast on Thursday 8 March, at the Ellerslie International Flower Show. All proceeds from the event will be donated to support Endometriosis New Zealand.

Deborah Bush (QSM), Chief Executive of Endometriosis New Zealand, said "endometriosis was one of the last medical taboo's of modern society. Awareness was essential as the disease affects approximately 126,000 girls and women in New Zealand and an estimated 176 million women worldwide." She said "using these statistics, it would potentially out-number all those with breast cancer, prostate cancer, diabetes I & II and AIDS in the 15 - 49 age group." The organisation relies solely on donations and fundraising to run its national services and programmes.

Tickets to the breakfast are now on sale and can be purchased from www.360endo.eventbrite.com

Endometriosis Facts

• Endometriosis (pronounced 'end-oh-me-tree-oh-sis') is a common disease affecting one in ten New Zealand women and girls
• It creates major human and financial burdens for individuals, families, health and welfare services and facilities, schools and work-place productivity
• Evidence shows that girls and women experience a diagnostic delay of 8+ years from first presentation of symptoms to a doctor
• Women are frequently misdiagnosed and may have undergone unnecessary and expensive investigations
• There are approximately 126,000 girls and women with endometriosis in New Zealand
• Canterbury women, in particular, are more vulnerable than ever as stress often makes chronic pain and symptoms worse. The demand on the services of Endometriosis New Zealand are greater than ever, however the ability to respond to the demand has been compromised by losses incurred through the cancellation of fund raising events from damage incurred by the Canterbury earthquakes.

http://www.nzendo.co.nz/

http://www.nzdoctor.co.nz/un-doctored/2012/march-2012/02/international-endometriosis-awareness-month.aspx

Tuesday, February 21, 2012

Santorum pose to questions Obama's world’s view Christian’s faith ~ a world with no birth control pills ?

Santorum pose to questions Obama's world’s view Christian’s faith
http://www.examiner.com/public-policy-in-cincinnati/santorum-pose-to-questions-obama-s-world-s-view-christian-s-faith

Article exerpt
"There is an illness that attacks women that is called endometriosis which can be controlled by birth controlling attention.


Endometriosisis defined as a gynecological medical condition in which cells from the lining of the uterus (endometrium) appear and flourish outside the uterine cavity, most commonly on the ovaries.



The uterine cavity is lined by endometrial cells, which are under the influence of female hormones. These endometrial-like cells in areas outside the uterus (endometriosis) are influenced by hormonal changes and respond in a way that is similar to the cells found inside the uterus. Symptoms often worsen with the menstrual cycle.



Endometriosis is typically seen during the reproductive years; it has been estimated that endometriosis occurs in roughly 5 to 10% of women. Symptoms may depend on the site of active endometriosis. Its main but not universal symptom is pelvic pain in various manifestations. Endometriosis is a common finding in women with infertility. How can these politicians be so insensitive and unconcern?



Nonetheless, Santorum continues to defends himself as he tried to justify his action. In that broadcast interview he said; "I am talking about his world view, and the way he approaches problems in this country. I think they're different than how most people do in America.”

Thursday, February 16, 2012

Female Sexual Function Improves After Lesion Surgery D.I.E.

Women with deep infiltrating endometriosis who undergo laparoscopic excision and postoperative combined oral contraceptive therapy have improved postoperative sexual function, according to a study published online Feb. 9 in The Journal of Sexual Medicine.


THURSDAY, Feb. 16 (HealthDay News) -- Women with deep infiltrating endometriosis (DIE) who undergo laparoscopic excision and postoperative combined oral contraceptive (COC) therapy have improved postoperative sexual function, according to a study published online Feb. 9 in The Journal of Sexual Medicine.

Mohamed Mabrouk, M.D., of the University of Bologna in Italy, and colleagues conducted a prospective study of 106 women with DIE to evaluate the impact of laparoscopic excision and postoperative COC therapy on sexual function.
Click link for full article: http://www.doctorslounge.com/index.php/news/pb/26819

Sunday, February 12, 2012

Gene variant linked to endometriosis

YALE (US) — Researchers may have identified a genetic basis of endometriosis, a condition that causes millions of women chronic pelvic pain and infertility.

The Yale University researchers’ discovery of a new gene mutation provides hope for new screening methods.


Published in the journal EMBO Molecular Medicine, the study explored an inherited mutation located in part of the KRAS gene, which leads to abnormal endometrial growth and endometrial risk.

Click here to read entire article: http://www.futurity.org/health-medicine/gene-variant-linked-to-endometriosis/

Thursday, February 02, 2012

Recurrence of Endometriosis and hip pain

I knew it! I have been trying to tell docs of my hip pain for 30 years now and have been brushed off or stared at blankly...I just love a little validation! Recurrence of Endometriosis???  I d on't know...what I have had happen to me is they had never been able to fully excise my endo and from what I read I am not sure it can all be visualised during the time of surgery....Lurpon??? No thank you....never again. I am almost 1 inch shorter than I use to be and dx'ed with osteoporosis at age 40!

Endometriosis and hip pain
Recurrence of Endometriosis and hip pain

Dear Ask The Doctor: Can endometriosis come back after surgery and spread to the hips

Dear Deesha: Recurrence of endometriotic lesions is stimulated by estrogens, the female hormones produced by the ovaries. During the normal menstrual cycle, blood levels of estradiol (the main estrogen) fluctuate between 40 and 400 pg/mL. These levels are necessary to achieve pregnancy but they also contribute to the recurrence of endometriosis.

Recurrence rate for endometriosis has been estimated to be 10% per year. One study found it to recur in 40% of women within 5 years after conservative surgery. There is a 6 times higher risk of recurrence after hysterectomy if the ovaries are not removed. Even in women who have their ovaries removed, there is still a risk of further recurrence of Endometriosis.

On occasion endometrial adhesions can restrict the hip ligaments, causing pain and limping. Hip joint pain that worsens in a cyclical fashion in line with the menstrual cycle will usually be caused by endometriosis. Surgical treatment to remove endometrial implants is sometimes undertaken in the hope of relieving the hip joint pain associated with endometriosis.
Last Updated ( Thursday, 19 January 2012 )
http://www.askthedoctor.com/topics-a-z/45-endometriosis/116458-recurrence-of-endometriosis-and-hip-pain.html

Thursday, January 12, 2012

Gynaecologist analyses women’s biggest sexual problems

Gynaecologist analyses women’s biggest sexual problems
On January 2, 2012 · In Health | 4:10 pm..
Abuja – Unlike men’s main sexual complaint — erectile dysfunction, women’s biggest sexual problem is caused by a combination of mental and physical factors, a doctor has analysed.

Dr Ekpi Philips, a Consultant Gynaecologist, said that common causes for a loss of sexual desire and drive in women could be interpersonal relationship issues, socio-cultural influences and peer pressure.

Others include partner performance problems, lack of emotional satisfaction with the relationship, the birth of a child and becoming a caregiver for a loved one.

“Medical problems such as mental illnesses, depression, or medical conditions such as endometriosis, fibroids, and thyroid disorders impact on a woman’s sexual drive both mentally and physically.

“Age, medications, certain antidepressants, blood pressure lowering drugs, and oral contraceptives can lower sexual drive.’’

Philips said that testosterone could also affect sexual drive in both men and women.

Testosterone is a hormone made by the body and helps to stimulate and maintain sexual function, maintain bone strength, among others.

“Testosterone levels peak in women’s mid-20s and then steadily decline until menopause, and drop dramatically,’’ he said.

Philips noted that lower sexual drive sets in when a woman experiences a significant decrease in interest in sex and it is having an effect on her.

According to him, sexual desire is more than just an issue of low libido or sex drive.

“Sexual drive is the biological component of desire which is reflected as spontaneous sexual interest including sexual thoughts, erotic fantasies, and daydreams.

“ It’s about your body signaling that it wants to be sexual.

“Whether or not there is any intention to act on it, we all have a certain level of drive.”

He explained that a woman carrying financial burdens of the home could lose interest in sex.

“For a growing number of women, declining hormones, job stress, relationship issues, and other problems are taking their toll in the bedroom.

“When a woman go to work and comes back late, think of bills to pay, prepares the children and think of the attitudes of the husband, such woman can never pick interest in sex’’.

Philips also explained that a woman who is ill and probably on medication, could have low sex drive.

He stated that relationships between the husband must be cordial for both parties to enjoy sex.

He added that loss of sexual desire, known in medical terms as hypoactive sexual desire disorder (HSDD), is the most common form of sexual dysfunction among women of all ages.

“These are not likely to be cured by merely using a pill’’.

He said that since the loss of sexual desire in women was caused by a combination of factors, it required more than an approach to fix the problem.

He advised that putting the desire back in women’s sex lives would require putting her on sex therapy and relationship counseling.

“Changing medications or altering the dose, addressing underlying medical conditions of the woman and the use of vaginal estrogens, testosterone therapy, could help.’’

According to Philips, many gynaecologists recommend off-label uses of testosterone therapy for women with low sexual desire to restore testosterone to normal levels.

“In postmenopausal women, vaginal dryness may be treated with vaginal estrogen creams although no hormone or drug has been approved to treat sexual problems in women,’’ Philips added

http://www.vanguardngr.com/2012/01/gynaecologist-analyses-women%E2%80%99s-biggest-sexual-problems/

Tuesday, January 10, 2012

New Risks for Women with Endometriosis

New Risks for Women with Endometriosis
By Heidi Anne Duerr, MPH | January 3, 2012

Endometriosis affects as many as 6% of the general population. While some women with endometriosis remain asymptomatic, many women experience dysmenorrhea, dyspareunia, non-cyclical pelvic pain, and subfertility. Now, new research indicates that patients with endometriosis are also more likely to develop inflammatory bowel disease.
Read the rest here: http://hcp.obgyn.net/endometriosis/content/article/1760982/2012566

Thursday, December 08, 2011

Protagen Collaborates in Endometriosis Biomarker Project

Protagen Collaborates in Endometriosis Biomarker Project
Protagen AG
Protagen AG, a specialist for in-vitro diagnostics, has announced that it is to collaborate with Bayer HealthCare Pharmaceuticals on the clinical validation of Endometriosis biomarkers. The project will build on the results of the Endometriosis biomarker discovery study performed last year.

Endometriosis is a gynaecological condition which occurs in roughly 5-10% of women worldwide. It occurs when uterine cells grow outside of the uterine cavity, often on the ovaries. The debilitating condition can cause recurrent pelvic pain of varying severity, constipation, fatigue and infertility issues in sufferers.

Protagen has successfully developed the proprietary UNIarray® technology platform for the development of novel, non-invasive diagnostic tests based on auto-antibody signatures in human blood.

The ‘gold standard’ diagnostic test for endometriosis is currently laparoscopy, a visual inspection of the abdominal organs followed by surgical removal and examination of lesions. The collaborative project to be undertaken by Protagen AG and Bayer Healthcare Pharmaceutical, is aimed at employing the UNIarray® technology for the predictive diagnosis of Endometriosis.

“With the targeted advancement of the UNIarray® technology platform, Protagen has developed into a preferred partner for drug development companies”, states Dr. Peter Schulz-Knappe, CSO and Executive Vice President Diagnostics at Protagen, “now we can directly support our collaboration partners in pharma and biotech in all clinical Phases I-IV with the development of therapy specific diagnostic assays. Besides Endometriosis, our technology is applied in autoimmune diseases like Multiple Sclerosis, chronic inflammatory diseases and cancer. Cooperation partners are, amongst others, Bayer, Biogen-Idec und SuppreMol”.

In order to understand the biochemical and molecular biological processes of Endometriosis, new technologies like UNIarray® are becoming increasingly important. Improving the predictive diagnosis of Endometriosis should help to improve patient’s quality of life.

Saturday, December 03, 2011

Rise in Dangerous Type of Ovarian Cancer

Poon Chian Hui - Straits Times Indonesia | November 18, 2011

More women in Singapore are coming down with an aggressive form of ovarian cancer whose symptoms are vague and survival rate low.

In 1988, 5.2 percent of all ovarian cancers were of the type called clear cell carcinoma. In 2007, the figure went up to 13.4 percent.

Less than 40 percent of women who get it survive, even when the cancer is detected early, said Associate Professor Tay Sun Kuie of the Singapore General Hospital (SGH).

In contrast, other types of ovarian cancer have a survival rate of as high as 70 percent when discovered early.

Prof Tay led a study which looked at the profiles of 256 ovarian cancer patients seen at SGH from 2004 to 2009, and examined national trends based on data from the Singapore Cancer Registry from 1988.

Ovarian cancer is the fifth most common among women in Singapore after breast, colorectal, lung and uterus, and nearly 300 are diagnosed with it every year.

It affects one out of 18 female cancer patients, and some 40 percent of cases occur in those aged 55 and above. The clear cell type usually crops up earlier, in those aged 40 onwards.

The symptoms for clear cell carcinoma are vague, but it has been found to occur in women who have painful and irregular periods and who are mysteriously losing weight or their appetite.

The study also found that women who were never pregnant are 14 percent more likely to get this aggressive cancer, compared with ovarian cancer patients who had at least one child.

There is also a link to endometriosis, a disorder where the womb lining responsible for menstruation is found outside the womb, leading to severe menstrual cramps, chronic pain in the pelvic region and infertility.

Patients who have the clear cell type are nearly five times more likely to have endometriosis than those with other types of ovarian cancer.

Clear cell carcinoma is the most lethal of all ovarian cancers. Even with surgery and chemotherapy, up to 80 percent of sufferers fail to improve, even if they were diagnosed at an early stage.

Prof Tay, a senior consultant in obstetrics and gynaecology, said the cancer cells have special genes that makes them more resistant to chemotherapy drugs. "Giving the cancer cells medicine is like giving them water - it doesn't kill them," he said.

SGH decided to research clear cell carcinoma because the cancerous cysts resemble ordinary ones in ultrasound and computed tomography (CT) scans.

Cysts in the ovaries are common and normally harmless.

"The cyst looks just like an empty fish bowl," said Prof Tay. "It can confuse doctors... because of the seemingly harmless appearance."

This was the case for a patient known only as Madam Lim in the study, which was first presented at the Singapore International Congress of Obstetrics and Gynaecology in August.

The 41-year-old manager, who was married but never pregnant, had a history of endometriosis.

When her pain flared up again, she underwent ultrasound and CT scans which revealed a large cyst measuring 15cm in diameter.

During the operation to remove it, doctors realized she actually had clear cell ovarian cancer.

Her condition is currently stable after treatment.

As doctors "cannot possibly take out every cyst in all women", Prof Tay hoped the study would help doctors in better diagnosing this cancer by pointing out, for example, the link with endometriosis.

He said women who experience an unexplained loss of appetite and worsening symptoms of endometriosis may want to seek medical advice early.

"This doesn't mean that one should be alarmist, but women ought to be more aware of changes in their body," he said.

Reprinted courtesy of Straits Times Indonesia. To subscribe to Straits Times Indonesia and/or the Jakarta Globe call 021 2553 5055.


http://www.thejakartaglobe.com/international/rise-in-dangerous-type-of-ovarian-cancer/479337#Scene_1

Monday, November 21, 2011

Taking birth-control pills — but not for birth control

By Jennifer LaRue Huget
Oral contraceptives are quite the multi-taskers these days.

A new report finds that of the 11.2 million women ages 15 to 44 who use oral contraceptives, 86 percent do so primarily to prevent pregnancy, while the remaining 14 percent — 1.5 million women — take them solely for other reasons. Those reasons include easing menstrual cramps or pain, regulating menstrual cycles, relieving symptoms of endometriosis and controlling acne. The report further found that more than three quarters of a million women who take the pill report never having had sex.

The report was written and published by the nonprofit Guttmacher Institute (which works to “advance sexual and reproductive health and rights,” according to its Web site) and drawn from data collected through the federal National Survey of Family Growth.

The report could help clarify, or further muddy, the controversy over whether the federal government should require insurance companies to cover the cost of birth control, including oral contraceptives.

By Jennifer LaRue Huget | 07:00 AM ET, 11/18/2011

http://www.washingtonpost.com/blogs/the-checkup/post/taking-birth-control-pills--but-not-for-birth-control/2010/12/20/gIQAbKieVN_blog.html

Sunday, November 20, 2011

'Top Chef' Host Padma Lakshmi On Dealing With Her Chronic Pain From Endometriosis

Padma Lakshmi, an author, model and Emmy-nominated host of Bravo's "Top Chef," suffered chronic pain every month for 23 years before she was finally diagnosed with endometriosis at age 36.

"I even had regular exams, and I had an ovarian cyst removed. They said everything would be better, but it didn't, and that was the tip of the iceberg," Lakshmi, now 41, said in an interview with HuffPost. "If I had been diagnosed at 20, or 25, the quality of my life would have been drastically different."

Endometriosis is actually quite common, affecting 8.5 million women in North America, though many are not diagnosed until their mid-20s, according to the Endometriosis Foundation of America, a non-profit organization Lakshmi co-founded with her doctor, Dr. Tamer Seckin, MD, to educate girls and young women about the condition. Just last month, the foundation held a conference to teach nurses about endometriosis, as they are often the first to see potential signs of the condition.

Undiagnosed and untreated, endometriosis causes abnormally painful cramping, bloating and nausea, and can even lead to infertility, according to the Mayo Clinic. It's often confused for ovarian cysts, pelvic inflammatory disease and irritable bowel syndrome. There is no cure for the condition, which occurs when the endometrium (the tissue that lines the inner part of the uterus) grows outside of the uterus, most commonly on the ovaries, bowel or the tissue that lines the pelvis, according to the Mayo Clinic. Depending on the pain, painkillers, hormone therapy, surgery and even hysterectomy are options for treating the condition.

Risk factors for the condition include having a shorter-than-normal menstrual cycle, having never given birth and having a family history (a mom, aunt or sisters) of the disease, the Mayo Clinic reported.

Lakshmi's in the family history camp. Her mother had undiagnosed endometriosis, and so when Lakshmi grew up experiencing the severe pain every month, she thought "it was just my lot in life."

Click here to read the rest: http://www.huffingtonpost.com/2011/11/15/padma-lakshmi-endometriosis-chronic-pain_n_1094003.htm l

Thursday, November 17, 2011

Endometriosis slowly emerges as a debilitating Disease for Women

Endometriosis slowly emerges as a debilitating Disease for Women
PDF | Print | E-mail

Written by Cleophas Mutinda




Imagine a pain in your abdomen so excruciating that you are unable to get out of bed for several days every month. That is horrible enough, but when it continues 12 times a year for more than 27 years, majority of people would agree it is cruel.

Most women with endometriosis will recognise this shocking scenario as not imaginary, but very real. They know the misery of pelvic pain and have poignant stories of how endometriosis has devastated their lives with terrible suffering. Many women feel angry or despondent about being robbed off a normal life during teenage, adulthood and even sometime a ruined motherhood.

Endometriosis is a gynaecological condition, which occurs when, cells like the ones (endometrial cells) lining inside of the uterus (womb) grow outside, usually on the surfaces of organs in pelvic and abdominal areas. It can be found within the peritoneal cavity, on the ovaries and the bowels or bladder. In extremely rare cases, endometriosis can be found in lungs or other parts of the body. Endometriosis can affect any menstruating woman, from time of her first period to menopause, regardless of race, ethnicity or socio-economic status. Endometriosis rarely persists after menopause. The disorder, for which there is no absolute cure, affects over 70 million women and girls worldwide. Often stigmatized as simply “painful periods,” Endometriosis is a puzzling and widely misunderstood illness.

It is not known exactly what causes endometriosis. But over the years several theories have been advanced to explain the probable cause of the disease although none can fully explain the various clinical manifestations of the disease. A theory proposed by John Sampson in the 1920s, suggests that endometriosis may result from something called “retrograde menstrual flow”, in which some of the tissue that a woman sheds during her period flows back through the tubes and grows in the pelvic cavity. While studies show that retrograde menstrual flow is a universal phenomenon among women of reproductive age, the theory fall short of explaining why the tissues survive in some women, but fail in others. Another theory proposed by Iwanoff in 1898, claims that, the transformation of what we call coelomic epithelium into endometrial-like tissue may be a cause of endometriosis. This theory has been supported by experimental data. The induction theory, proposes that an endogenous factor can induce peritoneal cells to develop into endometrial tissue. This theory has been supported by experiments in rabbits.



Lymphatic or vascular hypothesis suggests that endometrial fragments may be transported through blood vessels or the lymphatic system to other parts of the body. This theory speculates how endometriosis ends up in distant sites, such as the lung, brain, or the skin. A genetic linkage has been adduced which claims that, this disease could be inherited, or result from genetic errors, making some women more prone to develop the condition than others.



Studies show that the risk of endometriosis is seven times greater if the disease has affected a first-degree relative. This theory has been supported by experiments in mouse model but has not been verified either in women. Immunological etiology (cause) has also been conjured since studies report that many women with endometriosis exhibit immunological abnormalities. It is speculated that the immune system may fail to clear the menstrual debris in the pelvic cavity, allowing the endometrial cells to implant and develop into endometriosis.



Also most scientists agree that endometriosis is exacerbated by oestrogen; a hormone involved in the thickening of the endometrium and appears to promote the growth of disease implants. Some studies have pointed out environmental factors like toxins may contribute to the development of endometriosis, though this theory has not been confirmed and remains controversial.



The most common symptoms of endometriosis are abdominal pain and infertility. Some studies have reported that endometriosis may occur in 30%-40% of women with infertility and the incidence of endometriosis in women with pelvic pain may be higher than 50%.



Endometriosis associated pain may include but not limited to extremely painful (disabling) menstrual cramps, chronic pelvic pain (which includes lower back pain and pelvic pain), pain during or after sex, painful bowel movements or painful urination during menstrual periods, heavy menstrual periods and bleeding between periods. The amount of pain a women feels is sometimes not linked to degree of endometriosis. Some women have no pain even though their disease is extensive, while others have severe chronic pelvic pain even though they have only few affected areas.

The relation between endometriosis and pain is still shrouded in the mist of intricate puzzle and ignorance. Many women with endometriosis feel pain during their periods. Normally, a woman’s menstrual cycle involves her endometrial tissue to build up, breaks down into blood and tissue debris, and is shed as her menstrual flow or period. This cycle of growth and shedding happens every month under normal condition. Endometriosis grows outside the uterus and also goes through a similar cycle, build-up, breakdown and bleed every month. The problem is the tissue is in the wrong place and can’t leave the body the way a woman’s period normally does. Studies show that as part of this process, endometriosis may spur the production of substances that may irritate the nearby tissue, as well as provoke the release of chemicals that cause or mediate pain. Over time, endometriosis areas can grow and become nodules or bumps on the surface of pelvic organs, or become cysts (fluid-filled sacs) in the ovaries and may cause the organs in the pelvic area to adhere together.

Endometriosis is more than just simple "killer" cramps. Women and girls around the world continue to suffer in silence with a disease that can be potentially devastating to every aspect of their lives. It can be so painful as to render a woman or teenager unable to care for herself or her family, attend work, school, or social functions, or go about her normal routine. Endometriosis has a negative impact on the individual quality of life, affecting both physical and emotional well-being. A study by the American Endometriosis Association, demonstrated that 81% of the endometriosis patients in USA were unable to work, including household chores, because of pelvic pain. Approximately 27% were incapacitated for 3 or more days and 87% complained of fatigue or low energy. These figures are indicators of enormous suffering, in addition to the healthcare costs incurred. The need to develop intervention strategies is eminent, a published poll reveals women have to wait an average of 11.7 years in US and 8 years in UK to get a correct diagnosis after the initial onset of symptoms and a patient will seek the counsel of five or more physicians before her pain is adequately addressed and diagnosed. Once diagnosed, it is not unusual for a patient to undergo repeat surgeries and embark on many different medical therapies in an attempt to treat her symptoms. Endometriosis is a bit puzzling. We do not know why it causes such extreme symptoms in some women, while less in others. The treatment options can sometimes be unsuccessful. Sadly, endometriosis is associated with menstruation, sex, infertility, and pain (taboos in many societies), thus it is a disease that is not well known, understood, or accepted in the general public. This is frustrating for those who suffer from endometriosis, and for those who care for someone with the disease.

There is no non-invasive test to diagnose endometriosis. In fact, the only gold standard diagnosis of endometriosis is a surgical procedure known as laparoscopy and confirm histologically by taking a biopsy of the suspicious tissue.

However, this is an expensive, minimally invasive procedure. Furthermore, a specialised surgeon is needed for adequate assessment of the pelvis, for recognition of the various types and appearances of the disease. If the patients decline surgery, this makes diagnosis a challenge, and therefore an experienced gynaecologist should be able to recognise symptoms suggestive of endometriosis. The fact that there is no non-invasive diagnostic test for endometriosis is frustrating for clinicians as well as for women with the disease and underscores the need for search of better diagnostic tools.

Since the cause of endometriosis remains unknown, a treatment that fully cures the disease is yet to be developed. Choosing a holistic, treatment option comes down to the individual woman's needs, depending on symptoms, age, and reproductive desires.

Pain is the most common symptom in many women with endometriosis, mainly managed by painkillers, which may vary from simple analgesics to non-steroidal anti-inflammatory drugs. Most researchers agree that endometriosis is exacerbated by oestrogen. Subsequently, hormonal treatments for endometriosis attempt to reverse oestrogen production in a woman's body and thereby alleviate symptoms. However, hormonal therapies have varying degrees of side effects, and unfortunately, whatever pain relief is achieved tends to be only temporary for many women. Most gynaecologists agree that laparoscopic surgery is the only way to diagnose and treat endometriosis. Laparoscopy involves a small cut or incision in the abdomen, inflating the abdomen with harmless gas, and then inserts a viewing instrument with help of light (Laparoscope) into the abdomen. The success of surgery depends largely on the skills of the surgeon and the thoroughness of the surgery. The aim is to remove all endometriosis lesions, cysts, and adhesions. Today, most endometriosis surgery is being done through the laparoscopy, although a full abdominal incision called a laparotomy may still be required in rare cases for extensive disease or bowel resections.

Although the prevalence of endometriosis is well documented in women living in the developed world, studies among African women are still limited. The current myth is that endometriosis rarely affects women of African origin. However, among African-American women in the USA, studies have shown endometriosis is one of the common indications for major gynaecological surgery and hysterectomy, and is associated with a high hospital costs. Although genetically, African-American and African women from the African continent are not necessarily identical given the known genetic admixture among the African-American population. Lack of awareness of endometriosis as a potentially disabling disease and poor access to state-of art diagnostic and therapeutic facilities has contributed to the meagre data on prevalence of the disease in the African population. There is need to initiate awareness campaign of endometriosis to reach all women in Africa. Also to highlight the general lack of information, facilitate endometriosis research efforts and draw attention to the impact and implications of the disease to healthcare systems in our country and the continent in general.

The writer is a Senior Scientist with special interest in endometriosis and ovarian cancer research

http://www.africasciencenews.org/en/index.php/health/63-health/194-endometriosis-slowly-emerges-as-a-life-threatening-disease-for-women